Shanghai Kindly Medical Instruments Co., Ltd.

SSE
1501
Stock
Yield per half year: 0%
Dividend yield: 1%
Sector: Healthcare

Shanghai Kindly Medical Instruments Co., Ltd.

554433221100

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
31.97 118.32 -72.98% 0 0%
P/S 7.17 16.05 -55.34%
P/BV 2.77 5.73 -51.63%
P/FCF 0 28.9 -100%
Ev/Ebitda 22.03 16.62 32.52%
Ev/S 6.86 17.13 -59.94%
Ev/FCF 0 26.49 -100%
E/P 0.029 0.0239 21.24%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
27.31 -47.67 -157.29% 27.31 0%
ROE 8.95 2.65 237.92%
ROA 4.69 3.24 44.9%
ROIC 0 0 0%
ROS 22.48 -59.32 -137.9%
ROCE 0 1.66 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.305 0.5881 -48.13% 0.305 0%
Nеt Debt/Ebitda 0 -0.1844 -100%
Debt/Ratio 0 0.1106 -100%
Debt/Equity 0 0.9261 -100%
Debt/Net Income 0.3705 5.27 -92.97%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.5/10
1 0.3202 212.35% 0 0%
Number of years of dividend growth 0 1.05 -100%
DSI 1 0.6806 46.94%
Average dividend growth 0 -1.23 -100%
Average percentage for 5 years 0 1.28 -100%
Average percentage for payments 0 87.72 -100%
Difference from average difference in sector 0.6798

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
6/10
0 26.24 -100%
Growth impulse Ebitda in 5 years 0 12.85 -100%
Growth impulse Net Income in 5 years 0 309.26 -100%
Growth impulse FCF in 5 years 0 45.01 -100%
Growth impulse EPS in 5 years 0 18.38 -100%
IP Score
5.71/10

Similar companies

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Haohai Biological Technology Co., Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Shanghai Pioneer Holding Ltd

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription